Biodesix, Inc.
NASDAQ:BDSX
Overview | Financials
Company Name | Biodesix, Inc. |
Symbol | BDSX |
Currency | USD |
Price | 1.39 |
Market Cap | 201,796,030 |
Dividend Yield | 0% |
52-week-range | 1.15 - 2.21 |
Industry | Diagnostics & Research |
Sector | Healthcare |
CEO | Mr. Scott Hutton |
Website | https://www.biodesix.com |
An error occurred while fetching data.
About Biodesix, Inc.
Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD